Progesterone R/NR3C3 Antibody (PR484) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Progesterone R/NR3C3
Concentration
1.0 mg/mL
Applications
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin)
Conjugate
Unconjugated
Host Species
Mouse
Research Discipline
Breast Cancer, Cancer
Formulation
10mM PBS - BSA free with No Preservative
Gene ID (Entrez)
5241
Immunogen
A progesterone receptor recombinant protein was used as the immunogen for the antibody. The specific epitope has not been mapped.
Primary or Secondary
Primary
Content And Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Clone
PR484
Dilution
Western Blot 0.5-1.0ug/ml, Flow Cytometry 0.5-1ug/million cells, ELISA 1-5ug/ml for coating, Immunocytochemistry/Immunofluorescence 0.5-1ug/ml, Immunoprecipitation 0.5-1ug/500ug protein lysate, Immunohistochemistry-Paraffin 0.5-1.0ug/ml, Immunohistochemistry-Frozen 0.5-1.0ug/ml, CyTOF-ready
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Alias
NR3C3PRNuclear receptor subfamily 3 group C member 3, progesterone receptor
Gene Symbols
PGR
Isotype
IgG1 κ
Purification Method
Protein G purified
Test Specificity
This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone. It is excellent for immunohistochemical staining of formalin/paraffin tissues.
Related Products
Description
- Progesterone R/NR3C3 Monoclonal specifically detects Progesterone R/NR3C3 in Human samples
- It is validated for Simple Western, Immunohistochemistry, Immunohistochemistry-Paraffin, CyTOF-ready.
Compare Similar Items
Show Difference
Antigen: Progesterone R/NR3C3
Concentration: 1.0 mg/mL
Applications: Western Blot, Flow Cytometry, ELISA, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin)
Conjugate: Unconjugated
Host Species: Mouse
Research Discipline: Breast Cancer, Cancer
Formulation: 10mM PBS - BSA free with No Preservative
Gene ID (Entrez): 5241
Immunogen: A progesterone receptor recombinant protein was used as the immunogen for the antibody. The specific epitope has not been mapped.
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Clone: PR484
Dilution: Western Blot 0.5-1.0ug/ml, Flow Cytometry 0.5-1ug/million cells, ELISA 1-5ug/ml for coating, Immunocytochemistry/Immunofluorescence 0.5-1ug/ml, Immunoprecipitation 0.5-1ug/500ug protein lysate, Immunohistochemistry-Paraffin 0.5-1.0ug/ml, Immunohistochemistry-Frozen 0.5-1.0ug/ml, CyTOF-ready
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Alias: NR3C3PRNuclear receptor subfamily 3 group C member 3, progesterone receptor
Gene Symbols: PGR
Isotype: IgG1 κ
Purification Method: Protein G purified
Test Specificity: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone. It is excellent for immunohistochemical staining of formalin/paraffin tissues.
Antigen: Progesterone R/NR3C3
Concentration: 1.0 mg/mL
Applications: Western Blot
Conjugate: Unconjugated
Host Species: Mouse
Research Discipline: Breast Cancer, Cancer
Formulation: 10mM PBS - BSA free with No Preservative
Gene ID (Entrez): 5241
Immunogen: progesterone receptor recombinant protein was used as the immunogen for the antibody. The specific epitope has not been mapped.
Primary or Secondary: Primary
Content And Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Clone: PR500
Dilution: Western Blot 0.5-1ug/ml
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Alias: NR3C3PRNuclear receptor subfamily 3 group C member 3, progesterone receptor
Gene Symbols: PGR
Isotype: IgG1 κ
Purification Method: Protein G purified
Test Specificity: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.
Antigen: Progesterone R/NR3C3
Concentration: 0.2mg/mL
Applications: Western Blot, Immunohistochemistry (Paraffin), SDS-Page
Conjugate: Unconjugated
Host Species: Mouse
Research Discipline: Breast Cancer, Cancer
Formulation: PBS with 0.05% BSA. with 0.05% Sodium Azide
Gene ID (Entrez): 5241
Immunogen: progesterone receptor recombinant protein was used as the immunogen for the antibody. The specific epitope has not been mapped.
Primary or Secondary: Primary
Content And Storage: Store at 4C.
Clone: PR500
Dilution: Western Blot 0.5-1ug/ml, Immunohistochemistry-Paraffin 0.5-1ug/ml, SDS-Page
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Target Species: Human
Gene Alias: NR3C3PRNuclear receptor subfamily 3 group C member 3, progesterone receptor
Gene Symbols: PGR
Isotype: IgG1 κ
Purification Method: Protein G purified
Test Specificity: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.